Background: Kallikrein-related peptidase 7 (KLK7) is overexpressed in pancreatic ductal
Introduction
Pancreatic cancer is the fourth most common cause of cancer-related deaths in men and women in the United States (1) . Similar to other epithelial cancers, the development of pancreatic ductal adenocarcinomas is multi-step, with intermediate steps being defined by a series of morphological changes and molecular alterations during progression from intraepithelial lesions to invasive carcinoma (reviewed in (2) (3) . Although our understanding of the genetic changes that accumulate during progression of low-grade pancreatic intraepithelial neoplasms (PanINs) to infiltrating adenocarcinomas has increased substantially in the past decade, prognosis of patients upon diagnosis remains extremely poor. Most patients present with inoperable, locally advanced or metastatic disease; thus, median survival times for patients diagnosed with locally advanced disease ranges between 6-10 months, compared to only 3-6 months for patients with metastatic disease (4) . Even patients who undergo resection of localized adenocarcinoma of the head of pancreas without metastatic spread have a median survival of only 13-15 months and a 15-20% rate of long-term survival (5) . Thus, numerous prognostic factors have been assessed for their impact on survival following surgical resection of pancreatic adenocarcinoma, and several have been shown to correlate with patient outcome, including clinicopathological staging (e.g., tumor size, lymph node status), tumor biology, intraoperative factors, adjuvant chemoradiation therapy, and immunohistochemical markers such as VEGF, Bcl-2, p16, and p53 (6-9).
We previously generated an expression profile of serine proteases expressed in both normal and adenocarcinoma pancreatic tissues, and found that kallikrein-related peptidase 7 (KLK7) is overexpressed in pancreatic ductal adenocarcinomas (10) . KLK7, a chymotryptic-like serine protease, was initially purified and characterized from human skin extracts and is thought to play a role in desquamation of human skin (11) (12) . Increasingly, however, the KLK7 4 transcript and/or KLK7 protein have been found to be overexpressed in human cancers. Other laboratories have demonstrated it overexpressed in ovarian (13) (14) , squamous cervical (15) , and breast cancers (16) . In the current study, we utilized immunohistochemistry to examine the expression of KLK7 in lesions representing stages of PDAC development and to determine whether there is a correlation between KLK7 expression and overall survival in patients with pancreatic adenocarcinoma. cases. After the initial analysis of the TMAs, full sections were prepared from PDAC tumor blocks obtained following surgical resection and 22 cases were found to contain the targeted components: normal pancreatic ducts, invasive cancer, and at least one grade of PanIN in the same section. These full sections of 22 cases were evaluated for KLK7 immunoreactivity quantitatively. The full sections were chosen to reduce the biases of the TMA, such as small area subject to heterogeneity effect and unbalanced representation of cases by a different number of cores due to technical reasons. The next step was to examine the association between KLK7 expression and prognosis. The Surveillance Epidemiology and End Results (SEER) Residual Tissue Repository (RTR) population-based pancreatic TMA was examined for KLK7 expression (generously provided by NCI's SEER program, Bethesda, MD, USA) (18) . The tissues within the TMA are linked to cases in cancer registries in Hawaii, Iowa, and Los Angeles, for which there are additional clinical and demographic data. The cases with tissues in the TMA can thus be compared with all cases in the population for representation and potential biases (18) . 
Immunohistochemical staining
Immunohistochemical staining was performed as previously described (10) . Briefly, formalin-fixed, paraffin-embedded sections were deparaffinized and rehydrated in xylene followed by graded ethanol. Following antigen retrieval, endogenous peroxidase activity was quenched by hydrogen peroxide treatment followed by a protein block (Dako serum-free protein block, Carpinteria, CA). Sections were incubated with a goat anti-hKLK7 antibody (R&D Systems, Minneapolis, MN, diluted 1:800) overnight in a humidified chamber at 4°C.
Immunoreactive staining was detected using a DAKO LSAB+ peroxidase system followed by hematoxylin counterstain.
Evaluation of immunohistochemical analysis
In the initial analysis of the TMAs, each spot was assessed for the presence of the following components: normal pancreatic ducts, three grades of PanIN, or invasive adenocarcinoma. expression correlates with morphological steps of disease progression, population-based TMAs were analyzed for associations between KLK7 positivity and clinical outcome. These TMAs were analyzed digitally using previously described techniques (19) (20) . Briefly, the KLK7-stained slide was scanned using an Aperio ScanScope scanning system (Aperio Technologies, Vista, CA). Each TMA spot was saved as a separate file, then all parts of the tissue except for the component of interest were erased using "Photoshop CS3" (Adobe Systems, San Jose, CA).
Then, the images were processed to generate two sets of files: tissue masks to limit analysis 7 within the selected areas and signal images to assess KLK7 staining intensity. The tissue masks were obtained by thresholding through a value separating the clear background of histological slides from the tissue. The signal images were generated by collecting the range of KLK7 brown color, erasing non-brown pixels and converting images into grayscale files. This step was standardized by recording an action (Photoshop CS3) and processing all images in one batch. Intensity of KLK7 signal (mean optical density, MOD) was measured within the mask areas using an image-analysis program based on language IDL 6.3 (ITT Visual Information Solutions, Boulder, CO), which has been used in earlier studies (20) (21) (22) .
The highest intensity value of background staining was measured in the visually negative pancreatic and non-pancreatic tissue included in the same TMA (subjected to the same methodological variables). This value, a MOD of 15, was used as the cut-point to dichotomize intensities as positive (if ≥15) or negative (if <15) for KLK7 expression.
Statistical analysis
Tissue microarrays were assessed via pairwise chi-square tests for differences in the percentage of KLK7-positive samples between PDAC, PanIN2/3, and PanIN1. Full sections were compared for trend with disease severity in the percentage of KLK7-positive cells using a case-stratified version of Spearman correlation analysis that employs a generalized CochranMantel-Haenszel (CMH) test with rank scores (23) in order to adjust for the expected dependency among different components from the same sample. For the population-based TMA, samples were categorized into groups based on the characteristics from the accompanying clinical data: 1) whether the sampled tumor was "primary" or "metastatic" and 2)
whether the patient underwent surgical resection (resectable tumor at presentation) or the tumor was unresectable (sampled at autopsy). Four samples classified as "resected metastatic" were excluded from the analysis since these were sampled at the time of presentation by resection, but were found to have a disease stage, which was designated as unresectable for other cases with the same stage. Stage-wise these cases were "unresectable", however sampled as "resectable" at presentation and by resection, thus raising questions of potential misclassification for members of this group. The remaining samples were stratified into three groups, "resected primary", "unresected primary", and "unresected metastatic". These were construed to be the three levels of a variable called Disease Group. KLK7 positivity was tested via chi-square test for associations with disease group, age (≤54, 55-64, 65-74, ≥75), gender (male versus female), tumor grade (poorly differentiated versus moderately or welldifferentiated), and clinical stage. The effect of KLK7 positivity on overall survival (OS) was explored in three phases. In the first phase, "subgroup analyses", the effect of KLK7 positivity within each disease group was visualized via Kaplan-Meier curves and assessed quantitatively via univariate Cox regressions. In the second phase, "two-factor analysis", the effect of KLK7 positivity was reassessed by fitting to the entire dataset a two-factor model consisting of Cox regression with KLK7, disease group, and their interaction as the predictors, in order to determine whether the notable variation in KLK7 effect between disease groups was statistically significant. In the third phase, "multivariate analysis", the two-factor model was expanded to include stage and age as additional predictors. Two-way interactions in addition to the KLK7-byDisease-Group term were screened via the Backward Elimination algorithm at P<0.05, but none qualified for incorporation into the final multivariate model. 
Results

KLK7 expression increases during progression from premalignant ductal lesions to invasive adenocarcinoma
Results of immunohistochemical (IHC) analyses of KLK7 on the TMA composed of preinvasive and invasive ductal lesions were consistent with those of previous analyses (10) . 
This trend was subjected to generalized CMH test with the cases as strata to yield a correlation chi-square of 41.78 (DF=1; P<0.0001) and corresponding value of 82.1% for the Spearman correlation between percent KLK7-positive cells and disease severity of the pancreatic epithelial component.
Associations between KLK7 expression, tumor characteristics, and demographics
To determine whether KLK7 expression in PDAC could be used as a prognostic indicator, we employed a population-based pancreatic cancer tissue microarray (TMA) assembled from tumor tissue in three cancer registries as part of the Surveillance, Epidemiology, and EndResults (SEER) Program of the National Cancer Institute (18) for immunohistochemical analysis of KLK7. To digitally analyze the staining for KLK7 on the TMA, the slide was scanned using an Aperio ScanScope scanning system (Aperio Technologies, Vista, CA). All intensity measurements were done digitally in epithelial cells using the brown color-selection measurement. Intensity values were dichotomized as described above, and then assessed for association with age (<54, 55-64, 65-74, >75), gender (male versus female), grade (poorly versus moderately or well-differentiated), tumor stage (localized versus metastatic disease) and disease group (unresected metastatic, unresected primary, and resected primary). Four samples from patients denoted as having resected metastatic disease were excluded from the analyses since they did not fall into the treatment and sampling protocols used for the other patients of the same disease stage and the number was too small to form a separate group. All four were negative for KLK7.
Of the remaining 124 PDAC cases examined, 70 (56%) were classified as positive and 54 (44%) as negative for KLK7 expression ( Table 2) Table 2) , rates of KLK7 positivity were significantly different (P=0.0002), being much lower in metastases (32%) than in primary tumors, both unresected (72%) and resected (69%). No significant associations were found between KLK7-positive expression and patient age or gender ( Table 2) .
Association of KLK7 expression with overall survival
One hundred nineteen deaths occurred among the 124 study subjects during 185. (Figure 3 ) disclosed that the effect of KLK7 expression depended on whether the tumor had been resected. Among subjects whose primary tumors had been resected, KLK7
expression had little impact on OS (Figure 3, panel A) . But among subjects whose primary tumors had not been resected, those with KLK7-positive tumors had a significantly shorter survival than those with KLK7-negative tumors (Figure 3, panel B) . Likewise, patients with unresected metastatic disease had a significantly shorter survival if their tumors stained positive (compared to negative) for KLK7 (Figure 3, panel C) . Moreover, the differences among these three groups in the strength of the KLK7 effect was statistically significant (P=0.041) under twofactor analysis adjusting for disease group, and also significant (P=0.032) under multivariate analysis adjusting for disease group, age, and stage (Figure 3, panel D) . 
pancreatic cancer cells by KLK7 (10) . β-catenin is sequestered at the plasma membrane through its interaction with E-cadherin and cleavage of the extracellular domain of E-cadherin has been associated with increased β-catenin nuclear accumulation and lymphocyte enhancer binding factor/T cell factor (LEF/TCF)-mediated transcription, including cyclin D1 (32) . Thus, expression of KLK7 in PanINs could play an indirect role in enhancing cell proliferation via shedding E-cadherin; however, the function of this protease in early preneoplastic events remains to be established.
When KLK7 expression was examined in 124 PDAC specimens, a significantly higher percentage of tumors graded as moderately or well-differentiated displayed KLK7-positive staining compared with those graded as poorly differentiated. Interestingly, when KLK7 mRNA expression was analyzed in a series of ovarian tumors, it was significantly higher in patients with high grade (G3) tumors (13) , whereas in patients with PDAC, increased KLK7 expression was associated with lower grade moderate/well differentiated tumors.
Analysis of overall survival among patients with KLK7-positive tumors was significantly different compared to OS of patients with KLK7-negative tumors, except among patients whose primary tumors had been resected. Among patients with unresectable disease, those with KLK7-positive tumors had significantly shorter survival than those with KLK7-negative tumors.
However, among patients with resected primary disease, there was very little difference in OS between KLK7 groups. A similar phenomenon of prognostic associations within a clinical subgroup has been reported for ovarian cancer, in which the OS of patients with KLK7-positive tumors was not significantly different compared with patients with KLK7-negative tumors overall, but significantly reduced when a subgroup of ovarian cancer patients, those with low grade tumors, was analyzed (13) . In studies of breast (16) , colorectal (33) (34) (35) , and intracranial (36) tumors, KLK7 expression was shown to be significantly associated with reduced OS. Similarly, in oral squamous-cell carcinoma, patients with intense staining for KLK7 (as well as KLK4) had 
